Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers
21 Luglio 2011 - 10:05PM
Marketwired Canada
Bradmer Pharmaceuticals Inc. (TSX VENTURE:BMR.H) announced today that it has
granted, subject to regulatory approval, options to directors and officers of
the company exercisable to acquire an aggregate of 1,500,000 common shares, at a
price of $0.10 per share, expiring July 21, 2021.
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Bradmer Pharmaceuticals (TSXV:BMR.H)
Storico
Da Set 2023 a Set 2024
Notizie in Tempo Reale relative a Bradmer Pharmaceuticals (Venture Exchange Canada (TSXV)): 0 articoli recenti
Più Bradmer Pharmaceuticals Inc. Articoli Notizie